Journal profile · ALLERGY-IMMUNOLOGY
Allergy Asthma & Immunology Research
ISSN 2092-7355 · eISSN 2092-7363 · Korean Academy of Asthma, Allergy and Clinical Immunology · SOUTH KOREA · Founded 2009
Allergy Asthma & Immunology Research: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 4.37; fully open access; APC about USD 1,000; median 127 days to acceptance (94 articles, last 24 months); community-reported acceptance: fairly easy; 62 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Allergy Asthma & Immunology Research is published by Korean Academy of Asthma, Allergy and Clinical Immunology and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Asthma and respiratory diseases, Allergic Rhinitis and Sensitization and Food Allergy and Anaphylaxis Research, together about 46.3% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Published bimonthly (January, March, May, July, September, and November), the journal features cutting-edge original research, brief communications, and state-of-the-art reviews in the specialties of allergy, asthma, and immunology, including clinical and experimental studies and instructive case reports. Contemporary reviews summarize information on topics for researchers and physicians in the fields of allergy and immunology. As of January 2017, AAIR do not accept case reports. However, if it is a clinically important case, authors can submit it in the form of letter to the Editor. Editorials and letters to the Editor explore controversial issues and encourage further discussion among physicians dealing with allergy, immunology, pediatric respirology, and related medical fields. AAIR also features topics in practice and management and recent advances in equipment and techniques for clinicians concerned with clinical manifestations of allergies and pediatric respiratory diseases.
From the journal's Aims & Scope
Research area (LetPub): ALLERGY-IMMUNOLOGY
Editor-in-chief Yoon-Seok Chang SeoulPublisher website
Editorial board by country: 3 in mainland China (about 3%); most named South Korea 74, United States 7, Japan 5, Mainland China 3, United Kingdom 2 (101 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Asthma and respiratory diseasesMedicine23.3%
- Allergic Rhinitis and SensitizationMedicine14.1%
- Food Allergy and Anaphylaxis ResearchMedicine8.9%
- Dermatology and Skin DiseasesMedicine7%
- Respiratory and Cough-Related ResearchMedicine5.7%
- Drug-Induced Adverse ReactionsMedicine4.3%
- Sinusitis and nasal conditionsMedicine3.5%
- Urticaria and Related ConditionsMedicine3.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Allergy | Zone 3 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Allergy | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
| Minor | Allergy | Zone 3 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedCASCAB AbstractsPublisher website
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 4.37LetPub ·
- Impact factor (publisher) 2024
- 4.3Publisher website ·
- 5-year impact factor (publisher)
- 4.5Publisher website ·
- CiteScore 2026-06
- 7.4LetPub ·
- CiteScore (publisher)
- 7Publisher website ·
- SJR 2026-06
- 1.24LetPub ·
- SJR (publisher)
- 0.85Publisher website ·
- SNIP 2026-06
- 1.39LetPub ·
- SNIP (publisher)
- 1.04Publisher website ·
- h-index
- 35LetPub ·
- h-index
- 81OpenAlex ·
- i10-index
- 772OpenAlex ·
- 2-year mean citedness
- 4.16OpenAlex ·
- Self-citation rate
- 2.3%LetPub ·
- Share of gold OA articles
- 99.37%LetPub ·
Volume
- Articles per year
- 54LetPub ·
Articles by year OpenAlex count · 1,225 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 63 | 63 | 21 |
| 2025 | 62 | 62 | 265 |
| 2024 | 60 | 60 | 483 |
| 2023 | 69 | 69 | 792 |
| 2022 | 60 | 60 | 1,092 |
| 2021 | 78 | 78 | 1,559 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
127 daysMedian, submission to acceptance · P25–P75 67 days – 184 days
- Acceptance to online
- median 72 days (95 articles)
- Submission to online
- median 226 days
- Sample
- 94 articles with submission and acceptance dates (112 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- Fairly easyLetPub ·
- Peer review
- Single-anonymous peer reviewPublisher website · model-extracted
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| Publisher website | USD 1,000 | — | — |
Other charges and waivers (author guidelines)
- Submission fee
- USD 40
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare6 items from the author guidelines
- Abstract
- ≤ 300 words
- Keywords
- 3–9
- Manuscript length
- ≤ 5,000 words
- Reference style
- Vancouver
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted3, with length limits
- brief communicationand should be written in free style. C. Brief Communication Brief Communications should not exceed 2,000 words (excluding the Abstract, References, and Figure/T…main text ≤ 2,000 words
- original articlectly: e-mail: aair.editor1@gmail.com A. Original Article The total length should not exceed 5,000 words (excluding the Abstract, References, and Table/Figure Le…main text ≤ 5,000 words
- review articleext, References, Tables, and Figures. A review article is limited to 6,000 words excluding the Abstract, References, and Figure/Table Legendmain text ≤ 6,000 words
Policy excerpts from the journal's websiteAuthorship, Conflicts of interest, Publication ethics, License & copyright, Peer review, Preprints
- Authorship A. Authorship and Contributorship
AAIR defines an "author" as a person whose participation in the work is sufficient for taking public responsibility for all portions of the content. Specifically, all authors should have made substantial contributions to all of the following: (1) conception and design of the study, acquisition of the data, or analysis and interpretation of the data. (2) drafting of the article or critical revision…
Source ↗Publisher website ·- Conflicts of interest E. Author Disclosure of Conflict of Interest
Each author must disclose all potential conflicts of interest by completing the AAIR Conflict of Interest Disclosure Form. A conflict of interest (COI) is a financial relationship or other set of circumstances that may affect or may reasonably be thought by others to affect an author's judgment, conduct, or manuscript. For the purposes of this policy, competing interests are defined as financial a…
Source ↗Publisher website ·- Publication ethics
Follows COPE guidelines Model summary
The AAIR will follow the guidelines by the Committee on Publication Ethics (COPE, http://publicationethics.org/) for settlement of any misconduct.
Source ↗Publisher website ·- License & copyright H. Copyright
Copyright policy Model summary
Acceptance of a copyright agreement will ensure the widest possible dissemination of an article. An e-mail (or letter) confirming receipt of the manuscript will be sent to the corresponding author, along with a Journal Publishing Agreement form. Upon acceptance of their article, the authors will be asked to sign the Journal Publishing Agreement (for more information on publishing and copyrights, s…
Source ↗Publisher website ·- Peer review
Follows ICMJE Uniform Requirements Model summary
AAIR has agreed to follow the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (the "Uniform Requirements") of the International Committee of Medical Journal Editors (ICMJE)
Source ↗Publisher website ·- Preprints F. Preprint Policy
Preprint policy Model summary
The AAIR journal supports the posting of submitted manuscripts on community preprint servers such as arXiv, bioRxiv or similar platforms. We do, however, ask the authors to respect the following summaries of our policies: (1) Preprint information must be disclosed at submission for reviewers and editors to be able to evaluate the preprinted information and compare it with the submitted manuscript.…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Korean Academy of Asthma, Allergy and Clinical Immunology
- Country or region
- SOUTH KOREA
- Language
- English
- Founded
- 2009
- ISSN
- 2092-7355
- Electronic ISSN
- 2092-7363
- Latest issue on the website
- Volume 18, Issue 4 (July 2026)
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Allergy Asthma & Immunology Research
What CAS zone is Allergy Asthma & Immunology Research in?
In the 2025 upgraded edition of the CAS Journal Ranking, Allergy Asthma & Immunology Research is in Zone 2 of Medicine, and in Zone 2 of the minor category Immunology / Allergy. In the 2026 Xinrui edition it is in Zone 2 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Allergy Asthma & Immunology Research?
The latest impact factor listed by LetPub is 4.37; CiteScore 7.4, h-index 81.
How long does peer review take at Allergy Asthma & Immunology Research?
Based on the dates recorded on 94 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 127 days (interquartile range 67–184 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Fairly easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Allergy Asthma & Immunology Research?
According to the journal's author guidelines: Abstract: ≤ 300 words; Keywords: 3–9; Manuscript length: ≤ 5,000 words; Reference style: Vancouver; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Allergy Asthma & Immunology Research based?
Of the 101 board members whose country the journal's board page names, 3 (about 3%) are in mainland China; the countries named most often are South Korea (74), United States (7) and Japan (5). Counted from the institutions listed on the board page; for reference only.
Which databases index Allergy Asthma & Immunology Research?
According to LetPub and DOAJ records, Allergy Asthma & Immunology Research is indexed in SCIE and Scopus. The journal's website also lists Web of Science, PMC, PubMed, CAS and CAB Abstracts; that list has not been checked against each database.
Is Allergy Asthma & Immunology Research open access, and what is the APC?
Allergy Asthma & Immunology Research is a fully open-access journal. APC about USD 1,000.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .